# US 2016/0251375 A1 · Methods and intermediates for preparing macrolactams

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251375 A1
- Document ID: US20160251375A1
- Status: Published application
- Kind: A1
- Application number: 15/029,876
- Filed: 2014-10-14
- Published: 2016-09-01
- Earliest claimed: 2013-10-18
- Assignees: Merck Sharp & Dohme Corp.
- Applicants: Merck Sharp & Dohme Corp.
- Inventors: Feng XU; Richard DESMOND; Guy R. HUMPHREY; Hongming LI; Ji QI; Rebecca T. RUCK; Zhiguo Jake SONG; Tao WANG; Yong-Li ZHONG; Jeonghan PARK; Laura Marie ARTINO; Richard John VARSOLONA
- Web page: https://patentgrep.com/patent/US20160251375A1

## CPC

- C07D 498/16: Peri-condensed systems
- C07C 27/20: by oxo-reaction
- C07C 29/36: increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C 29/58: by elimination of halogen, e.g. by hydrogenolysis, splitting-off (C07C29/124 takes precedence)
- C07C 45/00: Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C 45/63: by introduction of halogen; by substitution of halogen atoms by other halogen atoms
- C07C 69/14: of monohydroxylic compounds
- C07C 69/63: of saturated acids
- C07C 231/12: by reactions not involving the formation of carboxamide groups
- C07C 269/04: from amines with formation of carbamate groups
- C07C 271/34: with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07K 5/06034: {the side chain containing 2 to 4 carbon atoms}
- C07K 5/0808: {the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu}
- C07K 5/126: {Tetrapeptides}
- C07C 2601/02: with a three-membered ring
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention includes compounds useful as intermediates in the preparation of macrolactams, methods for preparing the intermediates, and methods for preparing macrolactams. One use of the methods and intermediates described herein is in the production of macrolactam compounds able to inhibit HCV NS3 protease activity. HCV NS3 inhibitory compounds have therapeutic and research applications.

## Claims

### Claim 1

A method of making compounds of Formula C:
wherein n is selected from the group consisting of 0, 1, 2, 3, 4, 5, 6, 7 and 8; X1 and X2 are each independently selected from the group consisting of Br, Cl and I; and R5 is selected from the group consisting of C1-8 alkyl, C3-8 cycloalkyl, aryl and heteroaryl groups and R5 is substituted by 0, 1, 2, 3 or 4 substituents independently selected from the group consisting of C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, aryl, halogen, —NH2 or —OH; said method comprising:
(1) reacting
where LG is selected from the group consisting of halogen atoms, —O—SO2R8, —O—PO(OR8)2 or a protecting group and each R8 is independently selected from the group consisting of C1-8 alkyl, C3-8 cycloalkyl, aryl and heteroaryl groups and each R8 is independently substituted by 0, 1, 2, 3 or 4 substituents independently selected from the group consisting of C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, aryl, halogen, —NH2 or —OH, and the protecting group is selected from —OSiR8 and —OR8, with a chiral alcohol and
to produce
where each R1 is independently selected from the group consisting of C1-8 alkyl, aryl and heteroaryl groups, or two R1 are taken, together with the O—P—O atoms to which they are attached, to form a ring containing 5-19 atoms; and where R2 and R3 are each selected from the group consisting of H, C1-8 alkyl and —O—C1-8 alkyl groups, or where R2 is H, and R3 is a —O—C1-8 alkyl group, or R2 and R3 are each H or C1-8 alkyl groups or are taken together with the nitrogen atom to which they are attached to form a ring containing 5-19 atoms;
(2) reacting
with a Grignard reagent to produce
where R4 is selected from the group consisting of C1-8 alkyl, substituted C1-8 alkyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl groups and R4 is substituted by 0, 1, 2, 3 or 4 substituents independently selected from the group consisting of C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, aryl, halogen, —NH2 or —OH;
(3) halogenating
to produce
where X1 and X2 are each independently selected from the group consisting of Br, Cl and I; and
(4) oxidizing
to produce oxygen-inserted compounds
where R5 is selected from the group consisting of C1-8 alkyl, C3-8 cycloalkyl, aryl and heteroaryl groups and R5 is substituted by 0, 1, 2, 3 or 4 substituents independently selected from the group consisting of C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, aryl, halogen, —NH2 or —OH.

### Claim 2 (depends on 1)

A method of making a compound of Formula B:
or a salt thereof, wherein n is selected from the group consisting of 0, 1, 2, 3, 4, 5, 6, 7 and 8; and R7 is selected from the group consisting of acetyl and
and R6 is selected from the group consisting of C1-8 alkyl, C3-8 cycloalkyl, aryl, and heterocycle groups and R6 is substituted by 0, 1, 2, 3 or 4 substituents independently selected from the group consisting of C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, aryl, halogen, —NH2 and —OH, and salts thereof; said method comprising:
preparing a compound of Formula C according to the method of claim 1; and
converting
or a salt thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein
in step (1) is prepared by:
reacting
where n is as defined in claim 1 and X is a halogen atom, with a magnesium source to produce
and
(ii) reacting
with
to produce
where LG is defined as in claim 1.

### Claim 4 (depends on 3)

The method of claim 3, wherein X is Br.

### Claim 5 (depends on 1)

The method of claim 1, wherein said converting
comprises:
(i) de-halogenating
to produce
(ii) reacting
with a reagent containing a leaving group to produce
where LG is said leaving group and is as defined in claim 1;
(iii) reacting
with a reagent selected from carboimides and
to produce
and
(iv) optionally forming a salt of

### Claim 6 (depends on 1)

The method of claim 1, wherein R7 is acetyl.

### Claim 7 (depends on 2)

The method of claim 2, wherein R7 is
or a salt thereof.

### Claim 8 (depends on 1)

The method of claim 1, wherein R6 is selected from the group consisting of C2-C6 alkyl groups.

### Claim 9 (depends on 2)

The method of claim 2, wherein R6 is tert-butyl.

### Claim 10 (depends on 1)

The method of claim 1, wherein LG is Cl.

### Claim 11 (depends on 1)

The method of claim 1, wherein, in step (1), the chiral alcohol is chlorohydrin.

### Claim 12 (depends on 1)

The method of claim 1, wherein, in step (1),

### Claim 13 (depends on 5)

The method of claim 5, wherein, in step (iii),
is reacted with

### Claim 14 (depends on 1)

The method of claim 1, wherein step (iii) is conducted in the presence of a promoter.

### Claim 15 (depends on 14)

The method of claim 14, wherein the promoter is selected from the group consisting of 2-hydroxypyridine-N-oxide, hydroxyl succinimide, imidazole and imidazole HCl salt.

### Claim 16 (depends on 5)

The method of claim 5, wherein step (iv) comprises forming a salt of the compound, wherein the salt is selected from tert-butylamine salt, dibenzylamine salt, and dicyclohexyl amine salt.

### Claim 17 (depends on 2)

The method of claim 2, wherein the compound of Formula B has the following structural formula:
or a salt thereof, said method comprising:
(1) reacting
with chlorohydrin and
to produce
(2) reacting
with a Grignard reagent to produce
(3) brominating
to produce
(4) oxidizing
to produce
(5) converting
(6) optionally converting
to a salt thereof.

### Claim 18 (depends on 17)

A method of preparing Compound A:
or a pharmaceutically acceptable salt thereof, said method comprising:
(a) producing a compound of Formula B according to claim 17,
(b) reacting
with
to produce
where PG is H or a protecting group selected from —OSiR8 and —OR8;
(c) and further comprising the steps of:

### Claim 19

A method of preparing Compound A:
or a pharmaceutically acceptable salt thereof, said method comprising:
(a) reacting
with
to produce
(b) reacting
with HATU to produce
(c) hydrogenating
to produce
(d) reacting
with NaOH, followed by HCl to produce
and
(e) reacting
with
in the presence of 1-ethyl-3-(3-dimethylaminiopropyl)carbodiimide, pyridine and tetrahydrofuran to produce Compound A.

### Claim 20

A compound selected from the group consisting of:
